Global HIV Drugs Market: Size, Share, Trends & Industrial Analysis 2015 to 2019 - PowerPoint PPT Presentation

About This Presentation
Title:

Global HIV Drugs Market: Size, Share, Trends & Industrial Analysis 2015 to 2019

Description:

Research Beam added a report “Global HIV Drugs Market 2015 to 2019”. About HIV HIV is a type of retrovirus that causes infection in human beings. AIDS is a life-threatening disease caused by this virus. In this disease certain white blood cells (lymphocytes) are destroyed, resulting in the loss of the body's ability to protect itself against infections. The major route of transmission of HIV infection is unprotected sex, contaminated needle, breast milk, and infected blood. HIV attacks the body's white blood cells, specifically a subset called CD4 or helper T cells. The anti-retroviral therapy is used to treat the patient and help the immune system fight the infection. This is mainly used to keep the level of the HIV low in the body. Enquiry @ Technavio's analysts forecast the global HIV drugs market to grow at a CAGR of 4.52% over the period 2014-2019. – PowerPoint PPT presentation

Number of Views:36

less

Transcript and Presenter's Notes

Title: Global HIV Drugs Market: Size, Share, Trends & Industrial Analysis 2015 to 2019


1
Global HIV Drugs Market 2015
No. Pages 84
Published on October - 2015
2
.
Report Overview
About Global HIV Drugs Industry 2015 Research
Beam added a report Global HIV Drugs Market 2015
to 2019. About HIV, HIV is a type of retrovirus
that causes infection in human beings. AIDS is a
life-threatening disease caused by this virus. In
this disease certain white blood cells
(lymphocytes) are destroyed, resulting in the
loss of the body's ability to protect itself
against infections. The major route of
transmission of HIV infection is unprotected sex,
contaminated needle, breast milk, and infected
blood. HIV attacks the body's white blood cells,
specifically a subset called CD4 or helper T
cells. The anti-retroviral therapy is used to
treat the patient and help the immune system
fight the infection. This is mainly used to keep
the level of the HIV low in the body.
Technavio's analysts forecast the global HIV
drugs market to grow at a CAGR of 4.52 over the
period 2014-2019. Get Full Details On
http//www.researchbeam.com/global-hiv-drugs-2015-
2019-market
3
.
Report Overview
Covered in this report This report covers the
present scenario and the growth prospects of the
global HIV drugs market for the period 2015-2019.
To calculate the market size, the report
considers revenue generated from the sales of
various generic and branded drugs and the
expected launch of drug candidates used in the
treatment of HIV infection.   Based on the class
of drugs, the market is segmented as follows
Multi-class combination products Nucleoside
reverse transcriptase inhibitors Non-nucleoside
reverse transcriptase inhibitors Protease
inhibitors Fusion inhibitors Entry inhibitors
- CCR5 co-receptor antagonist HIV integrase
strand transfer inhibitors
4
.
Report Overview
The report also presents the vendor landscape and
a corresponding detailed analysis of the top
vendors in the market. The vendor landscape
section includes a market share analysis of the
major vendors along with the competitive
performances of their product portfolios. In
addition, the report discusses the major drivers
that influence the growth of the market. It also
outlines the challenges faced by the vendors and
the market at large, as well as the key trends
emerging in the market.   Technavio's report,
Global HIV Drugs Market 2015-2019, has been
prepared based on an in-depth market analysis
with inputs from industry experts. The report
covers the Americas, APAC, and EMEA it also
covers the landscape of the market and its growth
prospects in the coming years. The report
includes a discussion of the key vendors
operating in this market. Key regions
Americas APAC EMEA
5
Report Overview
Key vendors Bristol-Myers Squibb Gilead
Sciences GlaxoSmithKline Johnson Johnson
Merck   Other prominent vendors AbbVie
AstraZeneca Boehringer Ingelheim Cipla
Daiichi Sankyo Emcure
6
Report Overview
Inflow of funds For a full, detailed list,
view our report   Market challenge Patent
expiries For a full, detailed list, view our
report   Market trend Increasing public
awareness For a full, detailed list, view our
report
7
Table Of Contents
Key questions answered in this report What will
the market size be in 2019 and what will the
growth rate be? What are the key market
trends? What is driving this market? What are
the challenges to market growth? Who are the
key vendors in this market space? What are the
market opportunities and threats faced by the key
vendors? What are the strengths and weaknesses
of the key vendors?  
8
Table Of Content
PART 01 Executive summaryHighlightsPART 02
Scope of the reportMarket overviewTop-vendor
offeringsPART 03 Market research
methodologyResearch methodologyEconomic
indicatorsPART 04 IntroductionKey market
highlightsEnquiry about this report _at_
http//www.researchbeam.com/global-hiv-drugs-2015-
2019-market/enquire-about-report
9
FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/global-hiv-drugs-2015-
2019-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE 1 (800) 910-6452 E-MAIL
sales_at_researchbeam.com
Write a Comment
User Comments (0)
About PowerShow.com